急性冠脉综合征的研究进展  

Research Progress in Acute Coronary Syndrome

作　　者：杨一帆 许慧宁[2] 

机构地区：[1]青海大学研究生院,青海 西宁 [2]青海大学附属医院老年科,青海 西宁

出　　处：《临床医学进展》2023年第7期11440-11447,共8页Advances in Clinical Medicine

摘　　要：根据世界卫生组织的调查发现,全球每年有1500人死于心脑血管疾病,其中半数以上死于急性冠脉综合征。随着日常生活方式的改变,我国ACS患者呈逐年上升趋势。从2004年至今,心脑血管疾病及其相关性疾病死亡居我国城乡居民总死亡原因的首位,高于肿瘤和其他疾病,占居民疾病死亡构成的40%以上。因此,早预测早管理成为了预防急性冠脉综合征发生的重要措施,越来越多的生物标志物被提及。According to the survey of the World Health Organization, there are 1500 people with cardio cere-bral vascular disease in the world every year, and more than half of them die of acute coronary syn-drome. With the changes in daily lifestyle, ACS patients in China are showing an increasing trend year by year. Since 2004, the death of cardio cerebral vascular disease and its related diseases has ranked first among the total causes of death of urban and rural residents in China, higher than tu-mors and other diseases, accounting for more than 40% of the death of residents. Therefore, early prediction and management have become important measures to prevent the occurrence of acute coronary syndrome, and more and more biomarkers have been mentioned.

关 键 词：急性冠脉综合征 单生物指标 多生物指标组合 综述 

分 类 号：R54[医药卫生—心血管疾病]